SYDNEY (Reuters) - Australia's CSL, the world's largest producer of blood plasma products, is trialling "dynamic pricing" of payments to donors to grow profit margins amid persistently high supply ...

CSL Plasma has satisfied terms of a court agreement to prevent discriminatory screening of donors based on gender identity, the Minnesota Department of Human Rights announced Tuesday. The progress ...

Nov 18 (Reuters) - Australian biotech firm CSL (CSL.AX), opens new tab said on Tuesday it would invest $1.5 billion in the U.S. to manufacture plasma-derived therapies, in a move to expand its ...